Alnylam to Webcast Presentation at Canaccord Genuity 45th Annual Growth Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the Canacc...
Will the webcast provide insight into cost‑structure or margin improvements for upcoming product launches?
How does this event compare to prior Alnylam investor conferences in terms of market impact?
What is the market's likely reaction if Alnylam announces setbacks or positive milestones in the presentation?
Symbol:
ALNY
22 days ago